FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/02/023093 [Registered on: 03/02/2020] Trial Registered Prospectively
Last Modified On: 04/02/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to compare the numbness effect of 0.75% ropivacaine and 0.5% bupivacaine in surgical removal of wisdom tooth of lower jaw  
Scientific Title of Study   A double blind randomized study to evaluate and compare the anaesthetic efficacy of 0.75% Ropivacaine and 0.5% Bupivacaine on the perioperative regional analgesia in impacted mandibular third molar surgery 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nisha Mishra 
Designation  Resident 
Affiliation  Peoples Dental Academy 
Address  Room No 101 Department of Oral and Maxillofacial Surgery Peoples Dental Academy Bhopal , MP

Bhopal
MADHYA PRADESH
462010
India 
Phone  9009013215  
Fax    
Email  nishamishra838@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Yogesh Sharma 
Designation  Professor 
Affiliation  Peoples Dental Academy 
Address  Room No 101 Department of Oral and Maxillofacial Surgery Peoples Dental Academy Bhopal , MP

Bhopal
MADHYA PRADESH
462010
India 
Phone  9826048261  
Fax    
Email  sharma.dryogesh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Yogesh Sharma 
Designation  Professor 
Affiliation  Peoples Dental Academy 
Address  Room No 101 Department of Oral and Maxillofacial Surgery Peoples Dental Academy Bhopal , MP

Bhopal
MADHYA PRADESH
462010
India 
Phone  9826048261  
Fax    
Email  sharma.dryogesh@gmail.com  
 
Source of Monetary or Material Support  
Self 
 
Primary Sponsor  
Name  Nisha Mishra 
Address  Room No 101 Department of Oral and Maxillofacial Surgery Peoples Dental Academy Bhopal , MP 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Nisha Mishra  Peoples Dental Academy  Room No 101 Department of Oral and Maxillofacial Surgery Peoples Dental Academy Bhopal , MP
Bhopal
MADHYA PRADESH 
9009013215

nishamishra838@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Peoples Dental Academy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Q899||Congenital malformation, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Bupivacaine   Bupivacaine 0.5% Dose- 1.5- 2ml Frequency- Once Route of Administration- Intra-Oral Infiltration and Nerve Block Duration of anesthesia- 4-5 hours 
Intervention  Ropivacaine  Ropivacaine 0.75% Dose- 1.5- 2ml Frequency- Once Route of Administration- Intra-Oral Infiltration and Nerve Block Duration of anesthesia- 4-5 hours  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Impacted Mandibular 3rd molar
 
 
ExclusionCriteria 
Details  Allergic to any of the local anaesthetic solution
Pregnant Women 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Onset of Local Anaesthesthetic solution
 
15 minutes 
 
Secondary Outcome  
Outcome  TimePoints 
Duration of Local Anaesthetic solution  1 hour 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "50"
Final Enrollment numbers achieved (India)="50" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/02/2020 
Date of Study Completion (India) 14/10/2021 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

The results obtained from this study revealed interesting applications in both clinical and future research on the topic. This study summarizes the unbiased direct comparison of 0.75% ropivacaine and 0.5% bupivacaine. From the results and discussion, this study states that ropivacaine provides a successful and higher rate of local conduction anaesthesia than bupivacaine local anaesthetic solution by providing- the faster onset of anaesthesia, greater depth of anaesthesia, greater duration of anaesthesia, lesser intraoperative pain and lesser intraoperative bleeding. In a comparison of the use of 0.75% ropivacaine and 0.5% bupivacaine local anaesthetic solutions in healthy patients, it could be hypothetically stated that 0.5% bupivacaine could result in mild cardiovascular problems.

Hence to conclude the following results of our study, the magnitude of perioperative pain reduction during the surgery of the lower wisdom tooth is comprehended through the local long-lasting anaesthetic 0.75% ropivacaine, over 2 mL 0.5% bupivacaine. Ropivacaine is better than bupivacaine in the management of pain with no such cardiovascular problems and can be used in regular dental practice.

 
Close